The programme explicitly seeks Africa-led scientific innovations with potential for impact and scale, which aligns with the venture's Nigeria-first telepharmacy model. The founder's regulatory expertise and focus on prescription-drug access in an LMIC setting fit the SDG-oriented mission, though the venture is pre-revenue and pre-incorporation, which may affect competitiveness for a science-focused grant.